Position in ARDX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$106,875,796
+$37,443,347 QoQ
Shares Held
17,842,370
+49.8% QoQ
Ownership
7.22%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Derivatives in ARDX
reported options exposure · as of Mar 31, 2026CallValue
$1,207,584
CallShares
201,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,466,124,984 across 340 Biotechnology names. ARDX ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
This page
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in ARDX
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $106,875,796 | 17,842,370 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $1,207,584 | 201,600 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $541,607 | 92,900 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $69,432,449 | 11,909,511 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $165,300 | 30,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $42,107,348 | 7,641,987 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $204,624 | 52,200 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $45,719,857 | 11,663,229 | Shares | Sole | 2025-08-14 | |
| 2025-06-17 | $42,954,811 | 12,099,947 | Shares | Sole | 2025-06-25 | |
| 2025-03-31 | $31,744,436 | 6,465,262 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,024,843 | 2,963,480 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $27,641,853 | 4,011,880 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $23,734,896 | 3,203,090 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,629,393 | 1,319,095 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $13,079,831 | 3,205,841 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $23,649,419 | 6,976,230 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $52,783,917 | 11,019,607 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $479,000 | 100,000 | Call | Sole | 2023-05-15 | |
| 2022-12-31 | $715,350 | 251,000 | Call | Sole | 2023-02-14 | |
| 2022-12-31 | $29,592,487 | 10,383,329 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,128,165 | 948,038 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $912,673 | 1,546,904 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $876,212 | 818,890 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $195,241 | 177,492 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,197,028 | 906,840 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,976,161 | 1,052,264 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,674,865 | 706,173 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,089,402 | 632,056 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,236,627 | 235,548 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,434,919 | 351,867 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $520,444 | 91,547 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||